The USFDA approves Zydus Cadila’s arthritis medication with 180 days of exclusivity

New Delhi, India: Zydus Cadila, a pharmaceutical company, said on Monday that it has obtained final clearance from the US Food and Drug Administration to commercialise Tofacitinib extended-release tablets, which are used to treat rheumatoid arthritis. The medication has been approved by the US Food and Drug Administration (USFDA) in 11 mg and 22 mg doses, according to the firm.

According to Zydus, the firm was the first to file an abbreviated new drug application (ANDA) for Tofacitinib extended-release tablets 22 mg and so has 180-day exclusivity on this strength.

New Delhi, India: Zydus Cadila, a pharmaceutical company, said on Monday that it has obtained final clearance from the US Food and Drug Administration to commercialise Tofacitinib extended-release tablets, which are used to treat rheumatoid arthritis. The medication has been approved by the US Food and Drug Administration (USFDA) in 11 mg and 22 mg doses, according to the firm.

According to Zydus, the firm was the first to file an abbreviated new drug application (ANDA) for Tofacitinib extended-release tablets 22 mg and so has 180-day exclusivity on this strength.

 

 

 

Medically Speaking

Recent Posts

Mounjaro Launched in India: Price & Impact on Diabetes and Obesity

Eli Lilly, a leading American pharmaceutical company, has launched its groundbreaking diabetes and obesity medication,…

7 hours ago

Shocking Rabies Case in Greater Noida Challenges Common Misconceptions

A recent case of rabies transmission in Greater Noida has sent shockwaves through the community,…

7 hours ago

Punjab Government to Ban Energy Drinks in Schools and Colleges for Student Health

The Punjab government is set to ban high-caffeine energy drinks in schools, citing severe health…

8 hours ago

Experts Warn of Global Threat from Chronic Wasting Disease

Chronic Wasting Disease (CWD) is a highly contagious and fatal neurological disorder that affects deer,…

1 day ago

CDC Reschedules Vaccine Advisory Meeting to April 15-16

The Centers for Disease Control and Prevention (CDC) has announced a rescheduling of its vaccine…

1 day ago

India’s Specialty Chemicals Rebound, Pharma Exports Surge

India’s specialty chemicals industry and pharmaceutical exports continue to showcase resilience amid global uncertainties. As…

1 day ago